CLINERGY Health Research

What CLINERGY Health Research does

CLINERGY Health Research is a privately-held, independent Contract Research Organization (CRO) headquartered in São Paulo, Brazil, founded to address structural inefficiencies in the traditional CRO outsourcing model. The firm delivers integrated clinical development services across six service lines: Clinical Trial Planning, Regulatory Affairs, Clinical Operations, Data Analytics, Medical Writing, and Scientific Support. Its client base consists of small to mid-size international pharmaceutical and biotechnology companies, with disclosed sponsor relationships spanning France, the United States, the United Kingdom, Israel, and Asia. Therapeutic area coverage includes oncology, respiratory, analgesia, infectious diseases, cardiovascular and metabolic, nutrition, and advanced therapies.

The company operates with a deliberately lean team of 19 senior-level employees with global experience, using a selective engagement model that accepts only a limited number of projects each year to preserve quality and senior-level attention. Its go-to-market is direct enterprise sales to international sponsors targeting Brazil and Latin America, leveraging local ANVISA regulatory expertise and a 38-day Phase III startup capability as core value drivers. Revenue is generated through professional-services engagements (typically fixed-fee and milestone-based clinical trial contracts) sourced through founder-led business development and senior-level relationship selling rather than digital channels or marketplace platforms.

The business model is thus a high-touch, boutique professional-services model: premium-priced engagements executed by senior staff, capacity-constrained by design, with international sponsors paying for localized Brazilian and Latin American trial expertise. The firm positions itself as a "true extension" of client teams rather than a transactional vendor.

Name

CLINERGY Health Research

Legal name

CLINERGY Health Research

Website

https://clinergyhealth.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Boutique Brazilian CRO headquartered in São Paulo providing integrated clinical development services across six service lines—trial planning, regulatory affairs, clinical operations, data analytics, medical writing, and scientific support—to small and mid-size international pharma and biotech sponsors.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Contract research organization
• Clinical trial management
• Regulatory affairs services
• Clinical development CRO
• Pharmaceutical research services

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Research Services: CLINERGY generates revenue through providing contracted clinical research services to pharmaceutical and biotech companies. Services include clinical trial planning, regulatory affairs, clinical operations, data analytics, medical writing, and scientific support. Revenue is project-based, likely with a mix of fixed-fee and milestone-based arrangements typical of CRO engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

CLINERGY Health Research is a Brazilian Contract Research Organization (CRO) that delivers end-to-end clinical development services for life sciences companies conducting clinical research in Brazil. Its offering spans clinical trial planning, regulatory affairs (including ANVISA submissions), clinical operations, data analytics (eCRF, ePROs, central monitoring), medical writing, and scientific support, delivered by a 100% senior-level team acting as an extension of the client's team.

Product overview

CLINERGY Health Research is a Brazilian Contract Research Organization (CRO) offering a unified suite of clinical development services. The company provides six integrated service offerings: Clinical Trial Planning (development plans, study design, feasibility, operational manuals), Regulatory Affairs (strategy, applications, intelligence, lifecycle support), Clinical Operations (risk-based execution, project management, reimbursement, GCP audits), Data Analytics (eCRF, ePROs, data management, central monitoring), Medical Writing (protocols, reports, manuscripts), and Scientific Support (due diligence, advisory meetings, IIT support). These services are delivered by a senior-level team as a cohesive, flexible extension of client teams, focusing on selected projects to ensure high-quality outcomes in clinical development across Brazil.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Planning

Quantifiable outcome

• Phase III clinical trial application completed in 38 days from contract signature
• +4 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Worldwide Clinical Trials: Mid-size global CRO focused on complex clinical trials across multiple therapeutic areas. Comparable because it serves small-to-mid-size biotech and pharma sponsors with full-service clinical operations and regulatory expertise, occupying a similar mid-market position to CLINERGY.
• Premier Research: Mid-size CRO with therapeutic-area specialization including oncology and rare disease. Comparable because it targets small-to-mid-size biotech and pharma sponsors with full-service clinical development support, similar to CLINERGY's positioning.
• Allucent: Mid-size global CRO focused on small-to-mid-size biotech and emerging biopharma. Comparable because it provides full-service clinical operations, regulatory affairs, and biostatistics for sponsors running trials across multiple geographies, mirroring CLINERGY's service portfolio and target customer.

Broad incumbents

• Syneos Health: Global clinical and commercial solutions provider with biopharma services including clinical development. Comparable because it serves small-to-mid-size biotech and pharma across geographies, including Latin America, with end-to-end CRO capabilities.
• Parexel: Global CRO with operations in Latin America. Comparable because it provides clinical operations, regulatory affairs, and patient recruitment services across multiple therapeutic areas including oncology and advanced therapies, overlapping with CLINERGY's target sponsor base.
• Medpace: Mid-to-large global CRO with strong operations in Latin America, including Brazil. Comparable because it serves small-to-mid-size biotech and pharma with full-service clinical trial execution, but at much larger scale and with proprietary technology.
• Charles River Laboratories: Global CRO with preclinical-to-clinical services including site activation, regulatory, and biostatistics. Comparable because it competes for biotech and pharma clients running clinical programs and serves advanced therapy sponsors, though with a much broader service portfolio.
• IQVIA: Largest global CRO/commercial services provider with established Brazilian operations. Comparable because it competes for the same international pharma/biotech clients running trials in Brazil, but offers bundled global reach and proprietary technology platforms.
• ICON plc: Global CRO with significant Latin America presence following PRA Health Sciences acquisition. Comparable because it offers full-service clinical development including regulatory affairs and patient recruitment, competing for the same international biotech sponsors seeking Brazilian trial execution.

Emerging players

• Tigermed: Chinese-headquartered CRO with expanding global operations. Comparable as an emerging global CRO competing for international biotech sponsors and building out geographic coverage beyond its home market, similar to CLINERGY's position in Brazil.

Market position

Weaknesses5 records

Competitive moat3 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/clinergy-health-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CLINERGY Health Research